MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Inicio・Lista de Acciones・Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Inc

Cerrado

SectorSanidad

86.34 -2.03

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

85.18

Máximo

88.18

Métricas clave
By Trading Economics
Ingresos	5.4M -48M
Ventas	6M 57M
Margen de beneficios	-82.974
Empleados	414
EBITDA	5.1M -43M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+55.14% upside

Dividendos
By Dow Jones
Próximas Ganancias	6 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-1.2B 5.3B
Apertura anterior	88.37
Cierre anterior	86.34

Noticias sobre sentimiento de mercado

By Acuity

58%

42%

304 / 349 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

60 / 65.58 Soporte y Resistencia

Rhythm Pharmaceuticals Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

2 abr 2026, 17:11 UTC

Principales Movimientos del Mercado

Noticias de Eventos Importantes

Home Depot Shares Hit 52-Week Low as Iran War Threatens Housing Rebound

2 abr 2026, 17:10 UTC

Noticias de Eventos Importantes

ECB's Next Move Likely a Rate Rise, But Timing Unclear Amid Iran War, Villeroy Says

3 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

How Insulated Is the U.S. Economy From the Iran War? -- WSJ

2 abr 2026, 23:47 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Nikkei Might Rise After Thursday's Selloffs -- Market Talk

2 abr 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

Starbucks: Under the Terms of the Agreement, Funds Managed by Boyu Cap Now Hold a 60% Stake in Starbucks China Retail Ops >SBUX

2 abr 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

Starbucks: Retains 40% Ownership Interest and Continues to Own and License the Brand and Intellectual Property to JV >SBUX

2 abr 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

Starbucks: Joint Venture Is Designed to Enhance Starbucks Ability to Expand Footprint, Deepen Local Relevance >SBUX

2 abr 2026, 21:05 UTC

Adquisiciones, fusiones, absorciones

Starbucks and Boyu Cap: Finalize Joint Venture to Accelerate Long-Term Growth in China

2 abr 2026, 21:01 UTC

Noticias de Eventos Importantes

Investors Waver after Trump Speech on Iran, Ending Two-Day Surge in Stocks -- WSJ

2 abr 2026, 20:59 UTC

Adquisiciones, fusiones, absorciones

Starbucks and Boyu Capital Finalize China JV

2 abr 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

2 abr 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

2 abr 2026, 20:41 UTC

Ganancias

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2 abr 2026, 20:32 UTC

Charlas de Mercado

Higher Gas Prices Intensify K-Shaped Economy -- Market Talk

2 abr 2026, 20:30 UTC

Adquisiciones, fusiones, absorciones

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2 abr 2026, 20:09 UTC

Charlas de Mercado

Eli Lilly On More Equal Footing With Rival With Weight-Loss Pill -- Market Talk

2 abr 2026, 20:01 UTC

Adquisiciones, fusiones, absorciones

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2 abr 2026, 19:46 UTC

Charlas de Mercado

Is Oil the New GameStop? -- Market Talk

2 abr 2026, 19:35 UTC

Charlas de Mercado

U.S. Natural Gas Falls As Storage Injection Season Gets Under Way -- Market Talk

2 abr 2026, 19:29 UTC

Adquisiciones, fusiones, absorciones

SBA Communications Stock Jumps on Report of Sale Talks -- Barrons.com

2 abr 2026, 19:24 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Futures Jump Ahead of Long Weekend -- Market Talk

2 abr 2026, 19:20 UTC

Charlas de Mercado

Nike Has Yet to Show That a Turnaround is on Horizon -- Market Talk

2 abr 2026, 19:01 UTC

Adquisiciones, fusiones, absorciones

Union Pacific: ATDA Agreement to Guarantee Jobs for Life for Union Employees After Norfolk Southern Deal

2 abr 2026, 19:00 UTC

Adquisiciones, fusiones, absorciones

Union Pacific: Agreement Reached With American Train Dispatchers Association

2 abr 2026, 18:24 UTC

Adquisiciones, fusiones, absorciones

Globalstar Stock Rises on Amazon Deal Report. Why Apple Could Scuttle the Launch. -- Barrons.com

2 abr 2026, 17:44 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Supply Squeeze Puts Refiners in a Quandary -- Market Talk

2 abr 2026, 17:32 UTC

Noticias de Eventos Importantes

Amazon to Boost Fuel Surcharges on Third-Party Sellers as Costs Rise -- Barrons.com

2 abr 2026, 17:26 UTC

Ganancias

These Stocks Are Today's Movers: Tesla, Globalstar, Blue Owl, United Airlines, Carnival, Lumentum, and More -- Barrons.com

2 abr 2026, 17:17 UTC

Charlas de Mercado

Shares of Canadian Exports Heading to U.S. Continues to Slide -- Market Talk

2 abr 2026, 17:09 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Holds Gains After Trump Speech Disappointed Market -- Market Talk

Comparación entre iguales

Cambio de precio

Rhythm Pharmaceuticals Inc previsión

Precio Objetivo

By TipRanks

55.14% repunte

Estimación a 12 Meses

Media 136.71 USD 55.14%

Máximo 158 USD

Mínimo 105 USD

De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Rhythm Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

14 ratings

Comprar

Mantener

Vender

De acuerdo con 14 analistas que ofrecen calificaciones bursátiles a para Rhythm Pharmaceuticals Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

60 / 65.58Soporte y Resistencia

Recent bearish events outweigh bullish events.

All events are bullish.

Recent bullish events outweigh bearish events.

Sentimiento

By Acuity

304 / 349 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.